Non-invasive diagnosis of liver fibrosis and cirrhosis

作者：Lurie Yoav^*; Webb Muriel; Cytter Kuint Ruth; Shteingart Shimon; Lederkremer Gerardo Z

来源：World Journal of Gastroenterology, 2015, 21(41): 11567-11583.

DOI：10.3748/wjg.v21.i41.11567

• Liver
• Fibrosis
• Cirrhosis
• Non-invasive
• Serum biomarkers
• Ultrasonography
• Computerized tomography
• Magnetic resonance imaging

The evaluation and follow up of liver fibrosis and cirrhosis have been traditionally performed by liver biopsy. However, during the last 20 years, it has become evident that this "gold-standard" is imperfect; even according to its proponents, it is only "the best" among available methods. Attempts at uncovering non-invasive diagnostic tools have yielded multiple scores, formulae, and imaging modalities. All are better tolerated, safer, more acceptable to the patient, and can be repeated essentially as often as required. Most are much less expensive than liver biopsy. Consequently, their use is growing, and in some countries the number of biopsies performed, at least for routine evaluation of hepatitis B and C, has declined sharply. However, the accuracy and diagnostic value of most, if not all, of these methods remains controversial. In this review for the practicing physician, we analyze established and novel biomarkers and physical techniques. We may be witnessing in recent years the beginning of the end of the first phase for the development of non-invasive markers. Early evidence suggests that they might be at least as good as liver biopsy. Novel experimental markers and imaging techniques could produce a dramatic change in diagnosis in the near future.

• 出版日期2015-11-7